A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies.

NCT00462345 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: rituximab
DRUG: Methotrexate
DRUG: Corticosteroid or NSAID
DIETARY_SUPPLEMENT: Folate

Sponsor

Hoffmann-La Roche